Dehydrocorydaline Exerts Anti-Pancreatic Cancer Effects Through the PI3K/Akt/mTOR Pathway. - Yu, Qingmeng; Li, Ruiding; Li, Zhengyu; Wan, Zhexin; Lv, Kaikai; He, Chongyang; Sun, Jianfang; Jia, Shubing; Xu, Yijia; Zhao, Mingyi (Pharmaceuticals (14248247), 2026)